Alkaline phosphatase downregulation promotes lung adenocarcinoma metastasis via the c-Myc/RhoA axis.
Alkaline phosphatase downregulation promotes lung adenocarcinoma metastasis via the c-Myc/RhoA axis.
复制标题
碱性磷酸酶下调通过 c-Myc/RhoA 轴促进肺腺癌转移
DOI:
10.1186/s12935-021-01919-7
复制
发表时间:
2021-04-15
影响因子:
5.8
通讯作者:
Zhao L
中科院分区:
文献类型:
--
作者:
Lou Z;Lin W;Zhao H;Jiao X;Wang C;Zhao H;Liu L;Liu Y;Xie Q;Huang X;Huang H;Zhao L
BackgroundLung adenocarcinoma (LUAD) metastasis significantly reduces patient survival; hence inhibiting the metastatic ability of lung cancer cells will greatly prolong patient survival. Alkaline phosphatase (ALPL), a homodimeric cell surface phosphohydrolase, is reported to play a controversial role in prostate cancer and ovarian cancer cell migration; however, the function of ALPL in LUAD and the related mechanisms remain unclear.MethodsTCGA database was used to analysis the expression of ALPL, and further verification was performed in a cohort of 36 LUAD samples by qPCR and western blot. Soft-agar assay, transwell assay and lung metastasis assay were employed to detect the function of ALPL in LUAD progression. The qPCR, luciferase promoter reporter assay and western blot were used to clarify the molecular mechanisms of ALPL in promoting metastasis in LUAD.ResultsALPL was downregulated in LUAD, and the disease-free survival rate of patients with low ALPL was significantly reduced. Further studies showed that overexpression of ALPL in LUAD cell lines did not significantly affect cell proliferation, but it did significantly attenuate lung metastasis in a mouse model. ALPL downregulation in LUAD led to a decrease in the amount of phosphorylated (p)-ERK. Because p-ERK promotes the classical c-Myc degradation pathway, the decrease in p-ERK led to the accumulation of c-Myc and therefore to an increase inRhoAtranscription, which enhanced LUAD cell metastasis.ConclusionALPL specially inhibits the metastasis of LUAD cells by affecting the p-ERK/c-Myc/RhoA axis, providing a theoretical basis for the targeted therapy of clinical LUAD.
登录
查看更多内容
影响因子:
13.3
作者:
Huang H;Zhu J;Li Y;Zhang L;Gu J;Xie Q;Jin H;Che X;Li J;Huang C;Chen LC;Lyu J;Gao J;Huang C
通讯作者:
Huang C
DOI:
10.1083/jcb.153.5.1049
发表时间:
2001-05-28
期刊:
The Journal of cell biology
影响因子:
--
作者:
Gottardi CJ;Wong E;Gumbiner BM
通讯作者:
Gumbiner BM
影响因子:
64.5
作者:
Andreux, Penelope A.;Williams, Evan G.;Auwerx, Johan
通讯作者:
Auwerx, Johan
影响因子:
7.4
作者:
Lin, Lei;Liu, Yang;Li, Jinghong
通讯作者:
Li, Jinghong
影响因子:
29.4
作者:
Lammers, Willem J.;van Buuren, Henk R.;Hansen, Bettina E.
通讯作者:
Hansen, Bettina E.